Author:
O’Mahony Brian,O’Malley Andrew,Kerrigan Olan,McDonald Colm
Abstract
Abstract
Use of both cannabis and synthetic cannabinoids has been regularly linked to the development of psychotic illness. Thus, semisynthetic cannabinoids such as hexahydrocannabinol (HHC), which have a similar neurobiological profile to delta-9-THC, may also be expected to lead to psychotic illness. However, no such relationship has yet been reported in scientific literature. HHC is readily available online and in many vape shops in Ireland. Here, we present two cases of psychotic illness which appear to have been precipitated by use of legally purchased HHC and discuss its psychotogenic role and factors linked to its current widespread availability.
Publisher
Cambridge University Press (CUP)
Reference28 articles.
1. Pharmacology and effects of cannabis: a brief review;Ashton;The British Journal of Psychiatry,2001
2. European Monitoring Centre for Drugs and Drug Addiction (2023). Hexahydrocannabinol (HHC) and related substances, Lisbon.
3. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms;Bloomfield;Biological psychiatry,2014
4. Mongan, D , Millar, SR , Galvin, B (2021). The 2019-20 Irish national drug and alcohol survey: main findings.
5. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study;Di Forti;The Lancet Psychiatry,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献